Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare innovation. At City University of Hong Kong (CityUHK), a research team has ...

The project team led by Professor Zheng Zongli (right) of CityUHK’s Department of Biomedical Sciences, will focus on liver and cardiovascular genetic diseases, harnessing state-of-the-art “DNA surgery ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Scientists have designed an AI tool that can rapidly decode a brain tumor's DNA to determine its molecular identity during surgery - critical information that under the current approach can take a few ...

Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast Cancer Index. HR: hormone receptor, HER2: human epidermal growth factor receptor ...

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.

A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify stage II colon cancer patients who can most benefit from ...